What is the market doing?
What the tape says about VRDN
Viridian Therapeutics, Inc. is +28% over the past year while the S&P 500 is +20%: 7.5 points ahead of the market.
+28%
1-year return · S&P 500 +20%
- vs 200-day average
- −4.4%
vs 200-day average · below trend, but not far
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 31%
Below its 52-week high
Details›
- Last close2026-09-08
- $23.16
- 1 monthS&P 500 −0.30%
- +2.9%
- 1 yearS&P 500 +20%
- +28%
- 5 yearsS&P 500 +85%
- +92%
- vs 50-day average$20.44
- +13%
- 52-week high
- $33.78
- 52-week low
- $13.30
- Annualised volatility
- 69%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- $20M
| Year | Return |
|---|---|
| 2026 (year to date) | −26% |
| 2025 | +62% |
| 2024 | −12% |
| 2023 | −25% |
| 2022 | +48% |
| 2021 | +20% |
| 2020 | +128% |
| 2019 | −84% |
| 2018 | −71% |
| 2017 | +108% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +34% |
| Feb | 10 | 1 of 10 | −10% |
| Mar | 10 | 3 of 10 | −9.1% |
| Apr | 10 | 6 of 10 | −1.5% |
| May | 10 | 4 of 10 | +2.3% |
| Jun | 10 | 5 of 10 | +1.2% |
| Jul | 11 | 7 of 11 | +6.3% |
| Aug | 11 | 3 of 11 | −4.0% |
| Sep | 11 | 6 of 11 | +1.6% |
| Oct | 10 | 3 of 10 | −1.0% |
| Nov | 10 | 6 of 10 | +17% |
| Dec | 10 | 4 of 10 | −4.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.